Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6967749 | 1.00 | GLA (0.39) | GLANPSR1SIGMAR1HRH3ALDH1A1 | |
| SCHEMBL2847339 | 0.75 | MAPK1 (0.42) | GLANPSR1ALDH1A1CYP3A4SMN1; SMN2 | |
| SCHEMBL23255157 | 0.74 | ALDH1A1 (0.48) | ALDH1A1 | |
| SCHEMBL23255515 | 0.74 | ALDH1A1 (0.48) | ALDH1A1 | |
| SCHEMBL18886185 | 0.74 | ALDH1A1 (0.48) | ALDH1A1 | |
| SCHEMBL21678055 | 0.73 | CYP2D6 (0.49) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL23802727 | 0.72 | CYP2D6 (0.48) | HRH3ALDH1A1SMN1; SMN2 | |
| SCHEMBL23802816 | 0.72 | CYP2D6 (0.48) | HRH3ALDH1A1SMN1; SMN2 | |
| SCHEMBL6979156 | 0.70 | IDO1 (0.37) | GLANPSR1ALDH1A1SMN1; SMN2 | |
| SCHEMBL6970501 | 0.70 | IDO1 (0.37) | GLANPSR1ALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0821674-B1 | CYCLIC AMIDINO AGENTS USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS | SEARLE & CO (US) | 2003-08-06 | — | — | EP | claimed |